Details
Zusammenfassung: <jats:title>Abstract</jats:title> <jats:p>Glioblastoma is the most prevalent and malignant primary brain tumor in adults, and its response to current therapies is limited. Protein kinase CK2 is overexpressed in glioblastoma and regulates glioblastoma cell survival, proliferation, and migration and brain tumorigenesis. Targeting CK2 for glioblastoma treatment may benefit patients with glioblastoma. Clin Cancer Res; 19(23); 6335–7. ©2013 AACR.</jats:p>
Umfang: 6335-6337
ISSN: 1078-0432
1557-3265
DOI: 10.1158/1078-0432.ccr-13-2478